Healthy Investments Limited appointed Mrs. Nanditha Nagaraj as its Company Secretary and Compliance Officer effective October 15, 2026. The appointment was approved by the Board of Directors during a meeting held on the same date.

The decision was taken pursuant to Section 203 of the Companies Act, 2013, and Regulation 6 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board meeting commenced at 9:45 am and concluded at 9:52 am.

Professional background

Mrs. Nagaraj holds a B.Com degree from Bangalore University and has completed the Associate Company Secretary (ACS) course from the Institute of Company Secretaries of India. She brings over 8 years of experience in secretarial, accounting, finance, and compliance-related functions.

Her prior roles include serving as a Company Secretary for Stein Seal Company (India) Private Limited and One Ikgaii Cluster Kitchen Limited. Her expertise covers Companies Act, 2013 compliances, MCA filings, Board and General Meeting documentation, annual reports, share allotments, charge management, and FCGPR filings.

Regulatory disclosures

The company submitted the requisite disclosures under Regulation 30 of the SEBI LODR Regulations, read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026. The filing was signed by Director Krishna Babu Cherukuri.

Healthy Investments Limited has announced the closure of its trading window effective October 1, 2026. This measure precedes the upcoming declaration of the company's un-audited financial results for the second quarter and half year ending September 30, 2026.

Regulatory compliance and timeline

The closure is implemented pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal Code of Conduct. The restriction applies to all designated persons and their immediate relatives. The window will remain closed until 48 hours after the official declaration of the financial results.

Board meeting schedule

The company stated that the specific date for the Board Meeting to approve and consider the un-audited financial results will be intimated in due course of time. No further details regarding the meeting agenda or expected release date were provided in the initial filing.